# MESALAMINE
> **ANDA218410** · Abbreviated New Drug Application (Generic) · Sponsor: NOVAST LABS · Approved 2024-08-22
## Drug
- **FDA Application Number:** ANDA218410
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** MESALAMINE
- **Generic name:** MESALAMINE
- **Active ingredients:** MESALAMINE
- **Dosage form:** CAPSULE, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** NOVAST LABS
- **Manufacturer:** Ingenus Pharmaceuticals, LLC
- **First approval:** 2024-08-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218410)
---
*MORVS · CC0 1.0*